Viral aetiopathogenesis of tumors.
D001355:Alpharetrovirus / Q000276:immunology; D000906:Antibodies; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm; D002051:Burkitt Lymphoma / Q000188:drug therapy / Q000276:immunology; D002460:Cell Line; D002462:Cell Membrane / Q000276:immunology; D002471:Cell Transformation, Neoplastic; D003429:Cross Reactions; D003588:Cytopathogenic Effect, Viral; D004267:DNA Viruses / Q000276:immunology; D000939:Epitopes; D005455:Fluorescent Antibody Technique; D004854:Herpesvirus 4, Human / Q000276:immunology; D006648:Histocompatibility; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D007106:Immune Sera; D007111:Immunity, Cellular; D007519:Isoantigens; D007938:Leukemia / Q000276:immunology; D009052:Leukemia Virus, Murine / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000382:microbiology*; D009858:Oncogenic Viruses / Q000276:immunology*; D012328:RNA Viruses; D012075:Remission, Spontaneous; D013045:Species Specificity
D000906:Antibodies; D000951:Antigens, Neoplasm; D000939:Epitopes; D007106:Immune Sera; D007519:Isoantigens